{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T22:18:35Z","timestamp":1785449915069,"version":"3.56.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2017,3,20]],"date-time":"2017-03-20T00:00:00Z","timestamp":1489968000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,3,20]],"date-time":"2017-03-20T00:00:00Z","timestamp":1489968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1038\/bmt.2017.40","type":"journal-article","created":{"date-parts":[[2017,3,20]],"date-time":"2017-03-20T15:20:02Z","timestamp":1490023202000},"page":"1133-1137","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Autologous hematopoietic stem cell transplantation for pediatric multiple sclerosis: a registry-based study of the Autoimmune Diseases Working Party (ADWP) and Pediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT)"],"prefix":"10.1038","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7045-1806","authenticated-orcid":false,"given":"J","family":"Burman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Kirgizov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Carlson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Badoglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G L","family":"Mancardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Casanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Bembeeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Bader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Snowden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Farge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,20]]},"reference":[{"key":"BFbmt201740_CR1","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1136\/jnnp-2012-303996","volume":"84","author":"KE Harding","year":"2013","unstructured":"Harding KE, Liang K, Cossburn MD, Ingram G, Hirst CL, Pickersgill TP et al. Long-term outcome of paediatric-onset multiple sclerosis: a population-based study. J Neurol Neurosurg Psychiatry 2013; 84: 141\u2013147.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BFbmt201740_CR2","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1212\/WNL.0b013e31822facdd","volume":"77","author":"A Langer-Gould","year":"2011","unstructured":"Langer-Gould A, Zhang JL, Chung J, Yeung Y, Waubant E, Yao J . Incidence of acquired CNS demyelinating syndromes in a multiethnic cohort of children. Neurology 2011; 77: 1143\u20131148.","journal-title":"Neurology"},{"key":"BFbmt201740_CR3","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke JF . Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444\u20131452.","journal-title":"Neurology"},{"key":"BFbmt201740_CR4","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa067597","volume":"356","author":"C Renoux","year":"2007","unstructured":"Renoux C, Vukusic S, Mikaeloff Y, Edan G, Clanet M, Dubois B et al. Natural history of multiple sclerosis with childhood onset. N Engl J Med 2007; 356: 2603\u20132613.","journal-title":"N Engl J Med"},{"key":"BFbmt201740_CR5","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1212\/WNL.0b013e3181f4d821","volume":"75","author":"MP Amato","year":"2010","unstructured":"Amato MP, Goretti B, Ghezzi A, Lori S, Zipoli V, Moiola L et al. Cognitive and psychosocial features in childhood and juvenile MS: two-year follow-up. Neurology 2010; 75: 1134\u20131140.","journal-title":"Neurology"},{"key":"BFbmt201740_CR6","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1177\/0883073812464816","volume":"28","author":"L Julian","year":"2013","unstructured":"Julian L, Serafin D, Charvet L, Ackerson J, Benedict R, Braaten E et al. Cognitive impairment occurs in children and adolescents with multiple sclerosis: results from a United States network. J Child Neurol 2013; 28: 102\u2013107.","journal-title":"J Child Neurol"},{"key":"BFbmt201740_CR7","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nrneurol.2010.198","volume":"7","author":"B Banwell","year":"2011","unstructured":"Banwell B, Bar-Or A, Giovannoni G, Dale RC, Tardieu M . Therapies for multiple sclerosis: considerations in the pediatric patient. Nat Rev Neurol 2011; 7: 109\u2013122.","journal-title":"Nat Rev Neurol"},{"key":"BFbmt201740_CR8","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1177\/1352458510375568","volume":"16","author":"A Ghezzi","year":"2010","unstructured":"Ghezzi A, Banwell B, Boyko A, Amato MP, Anlar B, Blinkenberg M et al. The management of multiple sclerosis in children: a European view. Mult Scler 2010; 16: 1258\u20131267.","journal-title":"Mult Scler"},{"key":"BFbmt201740_CR9","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/sj.bmt.1700944","volume":"20","author":"A Fassas","year":"1997","unstructured":"Fassas A, Anagnostopoulos A, Kazis A, Kpainas K, Sakellari I, Kimiskidis V et al. Peripheral blood stem cell transplantation in the treatment of progressive multiple sclerosis: first results of a pilot study. Bone Marrow Transplant 1997; 20: 631\u2013638.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt201740_CR10","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1177\/1352458511429320","volume":"18","author":"G Mancardi","year":"2012","unstructured":"Mancardi G, Sormani M, Di Gioia M, Vuolo L, Gualandi F, Amato M et al. Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: the Italian multi-centre experience. Mult Scler 2012; 18: 835\u2013842.","journal-title":"Mult Scler"},{"key":"BFbmt201740_CR11","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.exphem.2012.07.003","volume":"40","author":"JL Shevchenko","year":"2012","unstructured":"Shevchenko JL, Kuznetsov AN, Ionova TI, Melnichenko VY, Fedorenko DA, Kartashov AV et al. Autologous hematopoietic stem cell transplantation with reduced-intensity conditioning in multiple sclerosis. Exp Hematol 2012; 40: 892\u2013898.","journal-title":"Exp Hematol"},{"key":"BFbmt201740_CR12","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1136\/jnnp-2013-307207","volume":"85","author":"J Burman","year":"2014","unstructured":"Burman J, Iacobaeus E, Svenningsson A, Lycke J, Gunnarsson M, Nilsson P et al. Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience. J Neurol Neurosurg Psychiatry 2014; 85: 1116\u20131121.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BFbmt201740_CR13","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1001\/jamaneurol.2014.3780","volume":"72","author":"RA Nash","year":"2015","unstructured":"Nash RA, Hutton GJ, Racke MK, Popat U, Devine SM, Griffith LM et al. High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for relapsing-remitting multiple sclerosis (HALT-MS): a 3-year interim report. JAMA Neurol 2015; 72: 159\u2013169.","journal-title":"JAMA Neurol"},{"key":"BFbmt201740_CR14","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1001\/jama.2014.17986","volume":"313","author":"RK Burt","year":"2015","unstructured":"Burt RK, Balabanov R, Han X, Sharrack B, Morgan A, Quigley K et al. Association of nonmyeloablative hematopoietic stem cell transplantation with neurological disability in patients with relapsing-remitting multiple sclerosis. JAMA 2015; 313: 275\u2013284.","journal-title":"JAMA"},{"key":"BFbmt201740_CR15","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1212\/WNL.0000000000001329","volume":"84","author":"GL Mancardi","year":"2015","unstructured":"Mancardi GL, Sormani MP, Gualandi F, Saiz A, Carreras E, Merelli E et al. Autologous hematopoietic stem cell transplantation in multiple sclerosis: a phase II trial. Neurology 2015; 84: 981\u2013988.","journal-title":"Neurology"},{"key":"BFbmt201740_CR16","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/S0140-6736(16)30169-6","volume":"388","author":"HL Atkins","year":"2016","unstructured":"Atkins HL, Bowman M, Allan D, Anstee G, Arnold DL, Bar-Or A et al. Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trial. Lancet 2016; 388: 576\u2013585.","journal-title":"Lancet"},{"key":"BFbmt201740_CR17","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1001\/jamaneurol.2013.5486","volume":"71","author":"CJ Bevan","year":"2014","unstructured":"Bevan CJ, Cree BA . Disease activity free status: a new end point for a new era in multiple sclerosis clinical research? JAMA Neurol 2014; 71: 269\u2013270.","journal-title":"JAMA Neurol"},{"key":"BFbmt201740_CR18","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1212\/WNL.0000000000002105","volume":"85","author":"N De Stefano","year":"2015","unstructured":"De Stefano N, Stromillo ML, Giorgio A, Battaglini M, Bartolozzi ML, Amato MP et al. Long-term assessment of no evidence of disease activity in relapsing-remitting MS. Neurology 2015; 85: 1722\u20131723.","journal-title":"Neurology"},{"key":"BFbmt201740_CR19","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1111\/bjh.13497","volume":"170","author":"A Panasiuk","year":"2015","unstructured":"Panasiuk A, Nussey S, Veys P, Amrolia P, Rao K, Krawczuk-Rybak M et al. Gonadal function and fertility after stem cell transplantation in childhood: comparison of a reduced intensity conditioning regimen containing melphalan with a myeloablative regimen containing busulfan. Br J Haematol 2015; 170: 719\u2013726.","journal-title":"Br J Haematol"},{"key":"BFbmt201740_CR20","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/bmt.2012.5","volume":"47","author":"NS Majhail","year":"2012","unstructured":"Majhail NS, Rizzo JD, Lee SJ, Aljurf M, Atsuta Y, Bonfim C et al. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Bone Marrow Transplant 2012; 47: 337\u2013341.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt201740_CR21","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s12883-015-0433-y","volume":"15","author":"A Ghezzi","year":"2015","unstructured":"Ghezzi A, Moiola L, Pozzilli C, Brescia-Morra V, Gallo P, Grimaldi LM et al. Natalizumab in the pediatric MS population: results of the Italian registry. BMC Neurol 2015; 15: 174.","journal-title":"BMC Neurol"},{"key":"BFbmt201740_CR22","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1007\/s00415-015-7979-x","volume":"263","author":"J Salzer","year":"2016","unstructured":"Salzer J, Lycke J, Wickstrom R, Naver H, Piehl F, Svenningsson A . Rituximab in paediatric onset multiple sclerosis: a case series. J Neurol 2016; 263: 322\u2013326.","journal-title":"J Neurol"},{"key":"BFbmt201740_CR23","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","volume":"83","author":"FD Lublin","year":"2014","unstructured":"Lublin FD, Reingold SC, Cohen JA, Cutter GR, Sorensen PS, Thompson AJ et al. Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology 2014; 83: 278\u2013286.","journal-title":"Neurology"},{"key":"BFbmt201740_CR24","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1177\/1352458511430704","volume":"18","author":"T Chitnis","year":"2012","unstructured":"Chitnis T, Tenembaum S, Banwell B, Krupp L, Pohl D, Rostasy K et al. Consensus statement: evaluation of new and existing therapeutics for pediatric multiple sclerosis. Mult Scler 2012; 18: 116\u2013127.","journal-title":"Mult Scler"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt201740.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt201740","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/bmt.2017.40","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/bmt201740.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T19:16:45Z","timestamp":1648063005000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt201740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,20]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["BFbmt201740"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2017.40","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,20]]},"assertion":[{"value":"26 October 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}